Henrik Zetterberg, M.D., Ph.D.

University of Gothenburg

Contact Information

Henrik Zetterberg, M.D., Ph.D.

Professional Information

Professor
University of Gothenburg

Financial Disclosure

Member reports the following financial or other potential conflicts of interest:
[Last updated: Feb 17, 2022]

HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Alector, Annexon, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Pinteon Therapeutics, Red Abbey Labs, Passage Bio, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program.